L. Say, D. Chou, A. Gemmill, Ö. Tunçalp, A. Moller et al., Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health, pp.323-356, 2014.

E. Chung and L. Leinwand, Pregnancy as a cardiac stress model. Cardiovasc Res, Mar, vol.15101, issue.4, pp.561-70, 2014.
DOI : 10.1093/cvr/cvu013

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941597

M. Sanghavi and J. Rutherford, Cardiovascular Physiology of Pregnancy. Circulation, Sep, vol.16130, issue.12, pp.1003-1011, 2014.

P. Descamps, H. Marret, C. Binelli, S. Chaplot, and P. Gillard, Modifications de l'organisme maternel au cours de la grossesse. Neurochir-J Société Neurochir Lang Francaise Société Francaise Neurochir, p.68, 2008.

B. A. Gouley, T. M. Mcmillan, and S. Bellet, IDIOPATHIC MYOCARDIAL DEGENERATION ASSOCIATED WITH PREGNANCY AND ESPECIALLY THE PUERPERIUM, The American Journal of the Medical Sciences, vol.194, issue.2, p.509, 1937.
DOI : 10.1097/00000441-193708000-00005

J. Demakis, S. Rahimtoola, G. Sutton, W. Meadows, P. Szanto et al., Natural Course of Peripartum Cardiomyopathy. Circulation, pp.1053-61, 1971.

G. Pearson, J. Veille, S. Rahimtoola, J. Hsia, C. Oakley et al., Peripartum Cardiomyopathy, JAMA, vol.283, issue.9, 2000.
DOI : 10.1001/jama.283.9.1183

K. Sliwa, D. Hilfiker?kleiner, M. Petrie, A. Mebazaa, B. Pieske et al., Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy, European Journal of Heart Failure, vol.92, issue.10 Suppl., pp.767-78, 2010.
DOI : 10.1093/eurjhf/hfq120

D. Hilfiker-kleiner, A. Haghikia, J. Nonhoff, and J. Bauersachs, Peripartum cardiomyopathy: current management and future perspectives, European Heart Journal, vol.36, issue.18, pp.1090-1097, 2015.
DOI : 10.1093/eurheartj/ehv009

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422973

L. Mielniczuk, K. Williams, D. Davis, A. Tang, R. Lemery et al., Frequency of Peripartum Cardiomyopathy, The American Journal of Cardiology, vol.97, issue.12, pp.1765-1773, 2006.
DOI : 10.1016/j.amjcard.2006.01.039

S. Brar, S. Khan, G. Sandhu, M. Jorgensen, N. Parikh et al., Incidence, Mortality, and Racial Differences in Peripartum Cardiomyopathy, The American Journal of Cardiology, vol.100, issue.2, pp.302-306, 2007.
DOI : 10.1016/j.amjcard.2007.02.092

D. Desai, J. Moodley, and D. Naidoo, Peripartum Cardiomyopathy: Experiences at King Edward VIII Hospital, Durban, South Africa and a Review of the Literature, Tropical Doctor, vol.37, issue.147, 1995.
DOI : 10.1177/004947559502500310

J. Fett, L. Christie, R. Carraway, and J. Murphy, Five-Year Prospective Study of the Incidence and Prognosis of Peripartum Cardiomyopathy at a Single Institution, Mayo Clinic Proceedings, vol.80, issue.12, pp.1602-1608, 2005.
DOI : 10.4065/80.12.1602

D. Hilfiker-kleiner and K. Sliwa, Pathophysiology and epidemiology of peripartum cardiomyopathy, Nature Reviews Cardiology, vol.25, issue.6, pp.364-70, 2014.
DOI : 10.1093/eurheartj/ehr485

A. Haghikia, E. Podewski, E. Libhaber, S. Labidi, D. Fischer et al., Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy, Basic Research in Cardiology, vol.33, issue.4, p.366, 2013.
DOI : 10.1007/s00395-013-0366-9

U. Elkayam, Clinical Characteristics of Peripartum Cardiomyopathy in the United States, Journal of the American College of Cardiology, vol.58, issue.7, pp.659-70, 2011.
DOI : 10.1016/j.jacc.2011.03.047

K. Sliwa, D. Hilfiker?kleiner, A. Mebazaa, M. Petrie, A. Maggioni et al., EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM, European Journal of Heart Failure, vol.19, issue.5, pp.583-91, 2014.
DOI : 10.1002/ejhf.68

P. Touraine and V. Goffin, Physiologie de la prolactine. EMC -Endocrinol, Feb, vol.2, issue.1, pp.50-76, 2005.
DOI : 10.1016/j.emcend.2004.10.002

D. Hilfiker-kleiner, K. Kaminski, E. Podewski, T. Bonda, A. Schaefer et al., A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy, Cell, vol.128, issue.3, pp.589-600, 2007.
DOI : 10.1016/j.cell.2006.12.036

I. Patten, S. Rana, S. Shahul, G. Rowe, C. Jang et al., Cardiac angiogenic imbalance leads to peripartum cardiomyopathy, Nature, vol.16, issue.7398, pp.333-341, 2009.
DOI : 10.1038/nature11040

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356917

C. Tiraby and D. Langin, PGC-1?, un co-activateur transcriptionnel impliqué dans le métabolisme. médecine/sciences, pp.49-54, 2005.
DOI : 10.1051/medsci/200521149

URL : http://www.erudit.org/revue/ms/2005/v21/n1/009990ar.pdf

K. Sliwa, O. Förster, E. Libhaber, J. Fett, J. Sundstrom et al., Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients, European Heart Journal, vol.27, issue.4, pp.441-447, 2006.
DOI : 10.1093/eurheartj/ehi481

K. Sliwa, D. Skudicky, G. Candy, A. Bergemann, M. Hopley et al., The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy, European Journal of Heart Failure, vol.101, issue.suppl 2, pp.305-314, 2002.
DOI : 10.1016/S1388-9842(02)00008-9

I. Bollen, E. Deel, D. Kuster, and J. Velden, Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart, Frontiers in Physiology, vol.2014, p.531, 2014.
DOI : 10.1155/2014/147040

URL : http://doi.org/10.3389/fphys.2014.00531

V. Dinic, D. Markovic, N. Savic, M. Kutlesic, and R. Jankovic, Peripartum Cardiomyopathy in Intensive Care Unit: An Update, Frontiers in Medicine, vol.121, issue.13, 2015.
DOI : 10.1161/CIRCULATIONAHA.109.901496

A. Dennis and J. Castro, Echocardiographic differences between preeclampsia and peripartum cardiomyopathy, International Journal of Obstetric Anesthesia, vol.23, issue.3, pp.260-266, 2014.
DOI : 10.1016/j.ijoa.2014.05.002

J. Halkein, S. Tabruyn, M. Ricke-hoch, A. Haghikia, N. Nguyen et al., MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy, Journal of Clinical Investigation, vol.123, issue.5
DOI : 10.1172/JCI64365DS1

D. Mcnamara, U. Elkayam, R. Alharethi, J. Damp, E. Hsich et al., Clinical Outcomes for Peripartum Cardiomyopathy in North America, Journal of the American College of Cardiology, vol.66, issue.8, pp.905-919, 2015.
DOI : 10.1016/j.jacc.2015.06.1309

K. Sliwa, L. Blauwet, K. Tibazarwa, E. Libhaber, J. Smedema et al., Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy. Circulation, pp.1465-73, 2010.

J. Clapp and E. Capeless, Cardiovascular Function Before, During, and After the First and Subsequent Pregnancies, The American Journal of Cardiology, vol.80, issue.11, pp.1469-73, 1997.
DOI : 10.1016/S0002-9149(97)00738-8

H. Patel, M. Berg, A. Barasa, C. Begley, and M. Schaufelberger, Symptoms in women with Peripartum Cardiomyopathy: A mixed method study, Midwifery, vol.32, pp.14-20, 2016.
DOI : 10.1016/j.midw.2015.10.001